Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-09

Clinical Trial Update: BraveMind: Advancing the Virtual Iraq/Afghanistan PTSD Exposure Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial of BraveMind, a virtual reality exposure therapy for post-traumatic stress disorder in Iraq/Afghanistan veterans, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Emory University | Conditions: Trauma, Post-Traumatic Stress Disorder | Phase 2 | Status: COMPLETED